Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.

MLA

Arimichi Okazaki, et al. “Glutaminase and Poly(ADP-Ribose) Polymerase Inhibitors Suppress Pyrimidine Synthesis and VHL-Deficient Renal Cancers.” Journal of Clinical Investigation, vol. 127, no. 5, May 2017, pp. 1631–45. EBSCOhost, https://doi.org/10.1172/JCI87800.

APA

Arimichi Okazaki, Gameiro, P. A., Christodoulou, D., Laviollette, L., Schneider, M., Chaves, F., Stemmer-Rachamimov, A., Yazinski, S. A., Lee, R., Stephanopoulos, G., Lee Zou, Iliopoulos, O., Okazaki, A., & Zou, L. (2017). Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers. Journal of Clinical Investigation, 127(5), 1631–1645. https://doi.org/10.1172/JCI87800

Chicago

Arimichi Okazaki, Paulo A. Gameiro, Danos Christodoulou, Laura Laviollette, Meike Schneider, Frances Chaves, Anat Stemmer-Rachamimov, et al. 2017. “Glutaminase and Poly(ADP-Ribose) Polymerase Inhibitors Suppress Pyrimidine Synthesis and VHL-Deficient Renal Cancers.” Journal of Clinical Investigation 127 (5): 1631–45. doi:10.1172/JCI87800.